Detalles de la búsqueda
1.
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis.
Mult Scler
; 27(9): 1374-1383, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32975468
2.
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes.
Life (Basel)
; 13(6)2023 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37374074
3.
Assessing the role of colonic and other anatomical sites uptake by [18 F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors.
Thorac Cancer
; 14(24): 2473-2483, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442801
4.
First-line immunotherapy in non-small cell lung cancer: how to select and where to go.
Expert Rev Respir Med
; 17(12): 1191-1206, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294292
5.
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.
JAMA Netw Open
; 6(11): e2341522, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37930700
Resultados
1 -
5
de 5
1
Próxima >
>>